These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 6802691)

  • 1. Long-term treatment of essential hypertension with Nadolol and Hydrochlorothiazide: a two-year follow-up.
    El-Mehairy MM; Shaker A; Ramadan M; Hamza S; Tadros SS
    J Int Med Res; 1982; 10(2):87-91. PubMed ID: 6802691
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is low-dose hydrochlorothiazide effective?
    Magee PF; Freis ED
    Hypertension; 1986 Jun; 8(6 Pt 2):II135-9. PubMed ID: 3013766
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term treatment of essential hypertension using nadolol and hydrochlorothiazide combined.
    El-Mehairy MM; Shaker A; Ramadan M; Hamza S; Tadros SS
    Br J Clin Pharmacol; 1979; 7 Suppl 2(Suppl 2):199S-203S. PubMed ID: 37875
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hydrochlorothiazide and nadolol in the treatment of hypertension.
    Olerud B
    Practitioner; 1982 Apr; 226(1366):785-7. PubMed ID: 7045854
    [No Abstract]   [Full Text] [Related]  

  • 5. Antihypertensive effect of oral timolol maleate and hydrochlorothiazide once daily compared with hydrochlorothiazide once daily.
    Durley Y; Cubberley RB; Thomas S
    Am J Hosp Pharm; 1981 Aug; 38(8):1161-4. PubMed ID: 7270561
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Minoxidil, nadolol, and a diuretic. Once-a-day therapy for resistant hypertension.
    Spitalewitz S; Porush JG; Reiser IW
    Arch Intern Med; 1986 May; 146(5):882-6. PubMed ID: 3963979
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Initial therapy of essential hypertension: diuretic or beta blocker?
    Finnerty FA
    J Fam Pract; 1980 Aug; 11(2):199-205. PubMed ID: 6106039
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Initial experience with a new long-acting beta-blocker, nadolol, in hypertensive patients.
    Hitzenberger G
    J Int Med Res; 1979; 7(1):33-8. PubMed ID: 33862
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Veterans Administration cooperative study on nadolol as monotherapy and in combination with a diuretic.
    Freis ED
    Am Heart J; 1984 Oct; 108(4 Pt 2):1087-91. PubMed ID: 6148868
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antihypertensive effect and tolerability of two fixed combination of metoprolol and hydrochlorothiazide followed by a long-term tolerance study with one combination.
    Liedholm H; Ursing D
    Ann Clin Res; 1981; 13 Suppl 30():45-53. PubMed ID: 7027893
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The results of the comparative study of nadolol, propranolol, prazosin and hydrochlorothiazide in patients with arterial hypertension in a 12-month stepped-plan treatment (cooperative research). The Working Group of the Cooperative Program to Study New Preparations in the Prevention of Arterial Hypertension. II. The results of combined therapy. Side effects. The reasons for dropouts. Conclusion].
    Metelitsa VI; Filatova NP
    Ter Arkh; 1991; 63(8):35-41. PubMed ID: 1792613
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessing duration of antihypertensive effects with whole-day blood pressure monitoring.
    Cheung DG; Gasster JL; Weber MA
    Arch Intern Med; 1989 Sep; 149(9):2021-5. PubMed ID: 2673118
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Evaluation of the antihypertensive effect and tolerability of nadolol administered alone or in association with bendroflumethiazide].
    Gragnoli G; Righi GA; Turchetti V; Mondillo S; Kristodhullu A
    Minerva Med; 1984 Nov; 75(43):2609-15. PubMed ID: 6392936
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nadolol and propranolol in the treatment of hypertension: a double-blind comparison.
    El Mehairy MM; Shaker A; Ramadan M; Hamza S; Tadros SS
    J Int Med Res; 1980; 8(3):193-8. PubMed ID: 6104614
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Titration of nadolol in the treatment of hypertension.
    Papadoyannis DE; Papazachos GA; Karatzas NB
    Eur J Clin Pharmacol; 1982; 22(6):487-9. PubMed ID: 7128661
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Field study: long-term antihypertensive therapy with the beta blocker nadolol in a once-a-day dosage - an outpatient study of Swiss medical practices].
    Bertel O; Conen D; Renggli I
    Schweiz Rundsch Med Prax; 1983 Feb; 72(8):264-8. PubMed ID: 6132374
    [No Abstract]   [Full Text] [Related]  

  • 17. Effects of therapy on renal impairment in essential hypertension.
    van Zyl A; Jennings AA; Byrne MJ; Opie LH
    S Afr Med J; 1992 Dec; 82(6):407-10. PubMed ID: 1465689
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dose-ranging study of the new beta-adrenergic antagonist nadolol in the treatment of essential hypertension.
    Frithz G
    Curr Med Res Opin; 1978; 5(5):383-7. PubMed ID: 26519
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term safety and efficacy of moexipril alone and in combination with hydrochlorothiazide in elderly patients with hypertension.
    White WB; Stimpel M
    J Hum Hypertens; 1995 Nov; 9(11):879-84. PubMed ID: 8583466
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Role of a beta adrenergic blocking agent nadolol (corgard) in prevention of arterial hypertension: a 6-month treatment (cooperative study)].
    Metelitsa VI; Filatova NP
    Kardiologiia; 1990 May; 30(5):8-14. PubMed ID: 2202853
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.